Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Forte Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −7 vs. Q2 2022
- Shares held
- 2.67M
- +358.2K (+15.5%) vs. Q2 2022
- Total value
- $2.85M
- −$153.0K (−5.1%) vs. Q2 2022
- New holders
- 4
- 8 more added
- Sold out
- 11
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 242 | $0 | 0.00% | −1,230−83.6% | Reduced |
| UBS Group AG | 33 | $0 | 0.00% | −1,859−98.3% | Reduced |
| JPMorgan Chase & Co | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 89 | $0 | 0.00% | +12+15.6% | Added |
| Royal Bank of Canada | 229 | $0 | 0.00% | +44+23.8% | Added |
| CWM, LLC | 66 | $0 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 453 | $0 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 35 | $0 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 100 | $110 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,405 | $1.00K | 0.00% | −335,634−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,080 | $2.00K | 0.00% | +500+86.2% | Added |
| Federated Hermes, Inc. | 3,270 | $3.00K | 0.00% | −25−0.8% | Reduced |
| Cutler Group LP | 4,387 | $4.00K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 10,760 | $12.0K | 0.00% | +10,760 | New |
| HSBC Holdings PLC | 11,906 | $13.0K | 0.00% | −865−6.8% | Reduced |
| Aries Wealth Management | 13,000 | $14.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 14,139 | $15.0K | 0.00% | +14,139 | New |
| Ergoteles LLC | 18,212 | $19.0K | 0.00% | −32,188−63.9% | Reduced |
| Group One Trading, L.P. | 19,053 | $20.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,383 | $22.0K | 0.00% | −12,419−37.9% | Reduced |
| Northern Trust Corp | 26,379 | $28.0K | 0.00% | +6,612+33.4% | Added |
| Bridgeway Capital Management, LLC | 36,865 | $39.0K | 0.00% | −50,000−57.6% | Reduced |
| State Street Corp | 41,664 | $45.0K | 0.00% | 00.0% | Unchanged |
| Old Well Partners, LLC | 68,600 | $73.0K | 0.06% | +68,600 | New |
| Two Sigma Investments, LP | 97,103 | $104.0K | 0.00% | −25,203−20.6% | Reduced |
| Millennium Management LLC | 131,094 | $140.0K | 0.00% | +72,097+122.2% | Added |
| Two Sigma Advisers, LP | 156,456 | $167.0K | 0.00% | −16,535−9.6% | Reduced |
| Geode Capital Management, LLC | 191,053 | $204.0K | 0.00% | +4,455+2.4% | Added |
| BlackRock Inc. | 212,061 | $226.0K | 0.00% | −1,982−0.9% | Reduced |
| Renaissance Technologies LLC | 444,129 | $475.0K | 0.00% | +227,429+105.0% | Added |
| Newtyn Management, LLC | 500,000 | $535.0K | 0.12% | +500,000 | New |
| Vanguard Group Inc | 647,293 | $692.0K | 0.00% | +186,159+40.4% | Added |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 193 | – | – | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −117,714−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −81,387−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −18,694−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −18,694−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,441−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,229−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −651−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −588−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −113−100.0% | Sold out |